We have investigated the functional consequences of three P/Q-type Ca 2؉ channel ␣1A (Ca v 2.1␣ 1 ) subunit mutations associated with different forms of ataxia (episodic ataxia type 2 (EA-2), R1279Stop, AY1593/1594D; progressive ataxia (PA), G293R). Mutations were introduced into human ␣1A cDNA and heterologously expressed in Xenopus oocytes or tsA-201 cells (with ␣ 2 ␦ and ␤1a) for electrophysiological and biochemical analysis. G293R reduced current density in both expression systems without changing single channel conductance. R1279Stop and AY1593/1594D protein were expressed in tsA-201 cells but failed to yield inward barium currents (I Ba ). However, AY1593/1594D mediated I Ba when expressed in oocytes. G293R and AY1593/1594D shifted the current-voltage relationship to more positive potentials and enhanced inactivation during depolarizing pulses (3 s) and pulse trains (100 ms, 1 Hz). Mutation AY1593/ 1594D also slowed recovery from inactivation. Single channel recordings revealed a change in fast channel gating for G293R evident as a decrease in the mean open time. Our data support the hypothesis that a pronounced loss of P/Q-type Ca 2؉ channel function underlies the pathophysiology of EA-2 and PA. In contrast to other EA-2 mutations, AY1593/1594D and G293R form at least partially functional channels.
We have investigated the functional consequences of three P/Q-type Ca 2؉ channel ␣1A (Ca v 2.1␣ 1 ) subunit mutations associated with different forms of ataxia (episodic ataxia type 2 (EA-2), R1279Stop, AY1593/1594D; progressive ataxia (PA), G293R). Mutations were introduced into human ␣1A cDNA and heterologously expressed in Xenopus oocytes or tsA-201 cells (with ␣ 2 ␦ and ␤1a) for electrophysiological and biochemical analysis. G293R reduced current density in both expression systems without changing single channel conductance. R1279Stop and AY1593/1594D protein were expressed in tsA-201 cells but failed to yield inward barium currents (I Ba ). However, AY1593/1594D mediated I Ba when expressed in oocytes. G293R and AY1593/1594D shifted the current-voltage relationship to more positive potentials and enhanced inactivation during depolarizing pulses (3 s) and pulse trains (100 ms, 1 Hz). Mutation AY1593/ 1594D also slowed recovery from inactivation. Single channel recordings revealed a change in fast channel gating for G293R evident as a decrease in the mean open time. Our data support the hypothesis that a pronounced loss of P/Q-type Ca 2؉ channel function underlies the pathophysiology of EA-2 and PA. In contrast to other EA-2 mutations, AY1593/1594D and G293R form at least partially functional channels.
Genetic defects within the pore-forming Ca v 2.1␣ 1 (␣1A) subunit of neuronal voltage-gated P/Q-type Ca 2ϩ channels are associated with inherited human neurological diseases, such as Familial Hemiplegic Migraine (FHM), 1 Episodic Ataxia Type 2 (EA-2), progressive cerebellar ataxia, and epilepsy (1) (2) (3) (4) (5) (6) . Therefore, neuronal Ca 2ϩ channel dysfunction represents an important pathophysiological mechanism that may also underlie more common forms of migraine, epilepsy, and neurodegenerative processes.
By mediating depolarization-induced Ca 2ϩ influx into dendrites, cell bodies, and nerve terminals, neuronal voltage-gated Ca 2ϩ channels control important neuronal processes. This includes fast neurotransmitter release, gene expression, neuronal plasticity, migration, and differentiation (7) . P/Q-type Ca 2ϩ channels are very tightly coupled to neurotransmitter release in many neurons (see e.g. Refs. 8 and 9) and mediate most of the depolarization-induced Ca 2ϩ current in cerebellar Purkinje cells (10) . They exist as hetero-oligomeric complexes of ␣1A subunits together with accessory subunits (especially ␣2␦ and ␤ (11)). ␣1A subunit-mediated neurotransmitter release is tightly controlled by other neurotransmitters (e.g. via protein kinase C phosphorylation and G-protein ␤␥ subunits (12) (13) (14) ) and by their direct association with synaptic vesicles through soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins (15) . Hence, these channels are ideally suited to fine-tune synaptic strength. This also explains why genetic defects, despite causing only minor changes in channel gating or expression, can lead to the above-mentioned clinical symptoms in humans and to the severe neurological abnormalities (absence epilepsy, dystonia, and ataxia) in spontaneous mouse mutants (16, 17) .
We (6, 18) and others (19) have recently described the consequences of seven different FHM missense mutations on P/Qtype Ca 2ϩ channel gating and expression. All these mutations form functional channels but cause detectable changes in Ca 2ϩ channel gating and/or affect current densities.
In contrast to FHM, most of the structural changes in the ␣1A subunit gene (CACNA1) associated with EA-2 cause ␣1A subunit truncations. Therefore, they are expected to lead to a complete loss of channel function. A mutation introducing a premature stop in codon 1820 (leading to an ␣1A lacking the C-terminal tail) is completely devoid of channel function after heterologous expression in Xenopus oocytes and even exerts a dominant negative effect on co-expressed wild type (WT) ␣1A (4). ␣1A mutation F1491S is an EA-2 missense mutant not causing truncation. Unlike FHM missense mutants, it also completely abolishes channel function (20) . These observations raise the interesting possibility that within the disease spectrum of autosomal dominant ␣1A Ca 2ϩ channel defects, a complete loss of function favors clinical symptoms dominated by episodic ataxia. * This work was supported in part by Austrian Science Fund (FWF) Grants P-14541 (to J. S.) and P-12689 (to H. G.), SFB Biomembranes Grant F-715 (to K. G.), the European Community Grant HPRN-CT2000-00082 (to J. S.), the Ö sterreichische Nationalbank (to J. S.), and the Dr. Legerlotz Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. To test this hypothesis further, we functionally characterized two additional mutations in human ␣1A causing EA-2, G293R, and AY1593/1594D (Fig. 1A) . The G293R mutation causes a severe progressive ataxia but also EA-2-like symptoms in some family members (3) . We also analyzed the EA-2 truncation mutant R1279Stop (5) to test if functional channel currents can be formed by association of two truncated ␣1A subunit molecule halves containing two functional pore-lining regions each.
EXPERIMENTAL PROCEDURES
Cloning of the Human ␣1A Subunit-␣1A cDNA was generated by reverse transcription-PCR from human cerebellum poly(A) ϩ RNA (CLONTECH) using proofreading Pfu DNA polymerase (Stratagene). First strand synthesis was performed by using the Ready-to-Go Tprimed first-strand kit (Amersham Biosciences). Six ␣1A fragments were amplified from first strands with PCR primers flanking suitable native restriction enzyme sites. PCR fragments were as follows (nucleotide numbers (nt) indicated in parentheses; asterisks indicate artificial restriction enzyme sites of the out-of-frame 5Ј and 3Ј termini introduced by PCR): A, SalI*-NotI (nt Ϫ5-602); B1, NotI-EcoRI (nt 602-1568); B2, EcoRI-AatII (nt 1568 -2875); C1, AatII-EcoRI (nt 2875-4319); C2, EcoRI-HindIII (nt 4319 -5274); and D, HindIII-BamHI* (5274 -6794). Fragments A, B1, and D were cloned into vector pBluescript SKϩ (Stratagene), and fragments B2, C1, and C2 were cloned into pSport-1 (Invitrogen). Sequence integrity of all PCR fragments was confirmed by sequence analysis (MWG Biotech, Ebersberg, Germany). The complete ␣1A cDNA clone was assembled from these fragments and finally introduced into the mammalian expression plasmid pGFP (21) . This ␣1A cDNA corresponds to the Q-type channel splice isoform as described previously (see Ref. 22 , GenBank TM accession number AF004883) with the exception of one splice deletion (Val 726 -Ala 728 ). Mutant ␣1A cDNAs-Mutations were introduced into ␣1A by applying the "gene-SOEing" technique as described previously (21) . Nucleotide positions (nt) of endonuclease restriction sites are given in parentheses. For heterologous expression in Xenopus laevis oocytes, ␣1A cDNA was cloned into the HindIII/BamHI polylinker sites of the polyadenylating transcription plasmid pNKS2 (a gift of O. Pongs) by coligating the HindIII-AatII fragment (5Ј-polylinker of pGFP Ϫ nt2875) and the AatII-BamHI* fragment (nt 2875-6794) into the corresponding restriction enzyme sites of pNKS2.
For heterologous expression in mammalian cells, the SalI*-BamHI* fragment (nt Ϫ5-6794) of ␣1A/pGFP was ligated into vector pCI-neo.
G293R was generated using a NotI-EcoRI cassette (nt 602-1568). For heterologous expression in X. laevis oocytes, the mutated cassette was subsequently ligated into NotI-AatII-cut ␣1A/pNKS2 (nt 602-2875) together with an EcoRI-AatII fragment (nt 1568 -2875) of ␣1A. For expression in mammalian cells, a NotI-SalI fragment (nt 602-3Ј-polylinker of pNKS2) of G293R/pNKS2 containing the respective mutation was cloned into NotI-SalI-cut ␣ 1 A/pCI-neo.
R1279Stop was generated using a SfiI-SspI cassette (nt 3267-3943). The mutated cassette was cloned into a NotI-KpnI (nt 602-4450) subclone in pBluescript SKϩ. The mutation was subsequently transferred to ␣1A/pNKS2 as a NotI-KpnI fragment to yield R1279Stop/pNKS2. R1279Stop/pCI-neo was generated as described for G293R. AY1593/1594D (designated AY/D) was constructed using a KpnIEcoRV cassette (nt 4450 -4933). To yield AY/D/pNKS2, the mutated cassette was cloned into KpnI-EcoRV-cut ␣1A/pNKS2. To generate AY/ D/pCI-neo, a NotI-XbaI (nt 602-3Јpolylinker of pNKS2) fragment of AY/D/pNKS2 was transferred to ␣1A/pCI-neo.
Transient Expression of ␣1A Mutants in Mammalian Cells-tsA-201 cells were maintained in Dulbecco's modified Eagle's medium/Coon's F-12 medium (Invitrogen) supplemented with 10% (v/v) fetal calf serum (Sebak), 2 mM L-glutamine, and 100 units/ml penicillin/streptomycin at 37°C and 7% CO 2 . For transient Ca 2ϩ channel expression, cells were grown to 80% confluency and plated at dilutions of 1:10 on glass coverslips 12 h before transfection by Ca 2ϩ phosphate precipitation using standard protocols. Human WT and mutant ␣1A subunits were expressed together with ␣2␦ and ␤1a (21). The cells were incubated at 30°C and 5% CO 2 12 h after transfection for 2-5 days prior to recording or membrane preparation.
For single channel analysis, HEK-293 cells were cultured and transfected as described previously (21) .
Expression of ␣1A Mutants in X. laevis Oocytes-Capped run-off poly(A)
ϩ cRNA transcripts from XbaI-linearized cDNA templates were synthesized according to Krieg and Melton (23) . ␣1 cRNA (3 ng) was co-injected with ␤1a (1 ng) and ␣2␦ (1 ng) subunit cRNAs into stage V-VI oocytes from X. laevis. To exclude effects of endogenous Ca 2ϩ -activated Cl Ϫ currents kinetic experiments were carried out in oocytes previously injected with 50 -100 nl of a 0.1 M 1,2-bis-(O-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid (BAPTA) solution. To test for a dominant negative effect, a 20-fold excess of R1279Stop cRNA was co-injected with ␣1A (0.04 ng) and ␤1a ϩ ␣2␦ cRNA, and currents were measured 2 days after injection.
Electrophysiological Recordings in Mammalian Cells-Whole-cell patch clamp experiments in tsA-201 cells were carried out at room temperature using an Axopatch 200B amplifier (Axon Instruments, Foster City, CA). Currents were recorded at sampling rates of 5 or 25 kHz, low-pass filtered at 2 or 5 kHz, and recorded directly onto a personal computer equipped with pCLAMP version 7.0. Borosilicate glass pipettes had a resistance of 2-3 megohms when filled with internal solution. Capacitance and series resistance compensations of 60% were used. Ba 2ϩ currents (I Ba ) through Ca 2ϩ channels were measured with the following solutions: pipette solution (in mM): 135 CsCl, 10 Cs-EGTA and 1 MgCl 2 , adjusted to pH 7.4 with CsOH; bath solution (in mM): 7.5-15 BaCl 2 , 10 HEPES, 150 choline Cl, and 1 MgCl 2 , adjusted to pH 7.4 with CsOH. All voltages were corrected for a liquid junction potential of Ϫ8 mV. Leak and capacitative currents were recorded using hyperpolarizing pulses. Raw currents were corrected for linear leak currents. Only data from cells with a voltage error Ͻ5 mV were analyzed. The voltage dependence of activation was determined from current-voltage (I-V) curves obtained by step depolarizations from a holding potential of Ϫ90 mV to various test potentials. I-V curves were fitted according to Equation 1,
where V rev is the extrapolated reversal potential of I Ba ; V is the membrane potential; I is the peak current; G max is the maximum conductance of the cell; V 0.5,act is the voltage for half-maximal activation; and The pipettes (3-5 megohms) were pulled from borosilicate glass (Clark Electromedical Instruments; Pangbourne, UK) and were coated with Sigmacoat (Sigma). Experiments were performed in a 200-l perfusion chamber at room temperature. For voltage clamp and current amplification, a EPC-7 amplifier (List, Darmstadt, Germany) was used. Cell-attached patches were clamped at Ϫ70 mV and depolarized to test potentials between Ϫ20 and ϩ40 mV using a Digidata 1200 Computer Interface (Axon Instruments, Foster City, CA) and pClamp software. Signals were low-pass filtered at 1 kHz and digitized with 5 kHz. Idealization of current records and analysis of open probability (P o ) were performed with a custom-made software (24, 25) .
Electrophysiological recordings in X. laevis Oocytes-1-6 days after cRNA injection I Ba was measured at 23°C using the two-microelectrode voltage clamp technique as described previously (26) . To quantify endogenous I Ba oocytes injected only with ␤1a and ␣2␦ were analyzed in parallel experiments ("control"). Only ␣1-injected oocytes expressing peak I Ba exceeding the highest endogenous currents by at least 3-fold were included into analysis. Data analysis and acquisition were performed by using the pClamp software package (version 6.0, Axon Instruments). Leakage correction was performed by adjusting the current traces by a factor calculated from the difference between the leak at Ϫ80 and Ϫ90 mV, respectively.
The voltage recording and current-injecting microelectrodes were filled with 2.8 M CsCl, 0.2 M CsOH, 10 mM HEPES, and 10 mM EGTA (adjusted to pH 7.4 with HCl) and had resistances of 0.7-6 megohms. The extracellular solution contained 40 mM Ba(OH) 2 , 50 mM NaOH, 2 mM CsOH, and 5 mM HEPES (pH adjusted to 7.4 with methanesulfonic acid).
The voltage dependence of activation was determined from I-V curves as described for patch clamp experiments. Holding potential was Ϫ80 mV.
Inactivation during depolarization was estimated during 3-s pulses from a holding potential of Ϫ80 mV to a test potential 10 mV positive to the peak potential (V max ) of the I-V relations of the respective cell. Traces were fit to a biexponential decay yielding time constants for the fast ( fast ) and slow ( slow ) component and the contribution of the fast component (% fast ).
Inactivation during pulse trains was determined by applying 1-Hz trains of 15 100-ms pulses to the V max from a holding potential of Ϫ60 and Ϫ80 mV, respectively.
FIG. 2. Functional expression of
␣1A and its mutants G293R and AY1593/1594D in tsA-201 cells and X. laevis oocytes. A, tsA-201 cells were transfected with equal amounts of ␣1 and auxiliary subunit cDNA as described under "Experimental Procedures." I Ba was measured 2-3 days after transfection in the indicated number of cells. Expression density (left panel) was determined by depolarizing pulses from a holding potential of Ϫ90 mV to voltages corresponding to the maximum of the corresponding I-V relationship (right panel, means Ϯ S.E., n ϭ 9 -15) and is indicated as pA/pF. Experiments were carried out with 7.5 mM Ba 2ϩ as charge carrier for wild type (Ⅺ) and G293R (q) and 15 mM Ba 2ϩ for AY1593/1594D, R1279Stop, and untransfected cells. *, statistically significant difference to WT ␣1A (p Ͻ 0.001, MannWhitney-U test). B, ␣1A mutants and auxiliary subunit cRNAs were co-injected into X. laevis oocytes as described under "Experimental Procedures." I Ba was measured 1-3 days (WT and G293R) and 2-6 days (AY1593/1594⌬) after injection (40 mM Ba 2ϩ as the charge carrier) in the indicated number of cells. Expression density (left panel) was determined by depolarizing pulses from a holding potential of Ϫ80 mV to V max (right panel, means Ϯ S.E., n ϭ 8 -19). *, ϩ statistically significant differences to WT ␣1A and to control, respectively (p Ͻ 0.01, Mann-Whitney-U test).
TABLE I Effects of mutations on activation and inactivation properties in channels expressed in X. laevis oocytes
The half-maximal voltage for activation (V 0.5, act ), the steepness of the curve at V 0.5, act (k act ), the half-maximal voltage for steady-state inactivation (V 0.5, inact ), and the steepness of the curve at V 0.5, inact (k inact ) were obtained by fitting the data to the Boltzmann equation. Data are means Ϯ S.E. 
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Recovery of I Ba from inactivation was studied using a double-pulse protocol. After a 3-s depolarizing prepulse from holding potential Ϫ80 mV to V max , the time course of I Ba recovery was determined at Ϫ60 mV by applying 300-ms test pulses to V max at various time intervals after the prepulse. Peak I Ba was normalized to the peak current amplitude measured during the prepulse. I Ba was then allowed to recover for 1 min at Ϫ100 mV. This double-pulse protocol was repeated individually for each recovery time interval in the same oocyte. The time course of recovery was fit to a biexponential decay yielding time constants for the fast ( fast ) and slow ( slow ) component and the contribution of the fast component (% fast ).
The voltage dependence of inactivation (steady state inactivation, holding potential Ϫ80 mV) was estimated from normalized inward currents elicited during steps to V max after 10-s steps to various holding potentials (conditioning pulses). The half-maximal voltage for steady state inactivation (V 0.5,inact ) and the slope factor of the curve (k inact ) were obtained by fitting the data to the Boltzmann equation.
Immunoblotting and Preparation of Affinity-purified Sequence-directed Antibodies-Experiments were carried out as described (27) using a sequence-directed antibody (anti-␣1A 1141-1156 ) against a synthetic peptide corresponding to residues 1141-1156 of the rabbit ␣1A sequence (GenBank TM accession number X57477 (28)). Statistics-All data are presented as mean Ϯ S.E. for the indicated number of experiments. Statistical significance was determined by unpaired Student's t test (or Mann-Whitney U test as indicated). Data were analyzed using Clampfit (Axon Instruments), Origin 5.0 (Microcal), and Statistica (StatSoft Inc).
RESULTS
We have recently shown that even small structural changes in Ca 2ϩ channel ␣1 subunits can dramatically affect ␣1 protein expression levels after heterologous expression in tsA-201 cells (21) . As we tested the possibility of a complete loss of function in our ␣1A EA-2 mutant constructs (Fig. 1A) , we first demonstrated that our mutants are efficiently expressed on the protein level (Fig. 1B) .
Next we investigated whether the mutant ␣1 subunits can form functional channels after heterologous expression in tsA-201 cells and X. laevis oocytes. Fig. 2A illustrates that G293R, but not AY1593/1594D and R1279Stop, yielded functional channels in transfected tsA-201 cells. The lack of expression of these two constructs was confirmed in three independent transfection experiments in which robust I Ba through G293R was always obtained. The G293R mutation significantly (p Ͻ 0.001, Mann-Whitney-U test, legend to Fig. 2 ) reduced expression density to 46% of wild type levels (␣1A, 129 Ϯ 19 pA/pF, n ϭ 28; G293R, 59 Ϯ 13 pA/pF, n ϭ 27) and shifted the I-V relationship to more positive voltages. To confirm the reduction of current density by G293R and to test whether functional expression of AY1593/1594D and R1279Stop could be accomplished in a different heterologous expression system, cRNAs of all three constructs were injected into X. laevis oocytes. The appearance of channel currents was then quantified by twoelectrode voltage clamp 1-6 days after injection. As in tsA-201 cells, no I Ba exceeding the endogenous oocyte Ca 2ϩ channel current was detected in R1279Stop-injected oocytes (I Ba Ͻ 350 nA, n ϭ 50).
I Ba density for G293R was also significantly (p Ͻ 0.01, Fig.  2B ) smaller, and the I-V relationship was again shifted to more positive voltages by about 6 mV ( Table I ). Note that higher Ba 2ϩ concentrations than in tsA-201 cells (40 versus 7.5-15 mM, legend to Fig. 2) were employed in oocyte experiments causing an overall shift of the I-V relationship to more positive potentials for both mutant and WT ␣1A currents. In contrast to tsA-201 cells, significant I Ba through AY1593/1594D could be measured in oocytes. AY1593/1594D-injected cells expressed I Ba that significantly exceeded the amplitudes measured for endogenous currents (p Ͻ 0.001, Fig. 2B ). This was observed in 10 of 22 independent injections.
A detailed characterization of the biophysical properties was carried out in oocytes because both mutants could be expressed and compared in this system. Like G293R, the V 0.5,act of AY1593/1594D was also significantly shifted to more positive voltages by about 6 mV compared with WT ␣1A (p Ͻ 0.01, Table I ). Both mutations accelerated voltage-dependent inactivation by decreasing the fast and slow time constant of the biexponential decay of I Ba and by enhancing the contribution of the fast component (Fig. 3, A and B) . The faster inactivation could also explain the more pronounced decay of peak G293R and AY1593/1594D I Ba during rapid pulse trains. After 15 100-ms pulses applied at 1 Hz (holding potential Ϫ60 mV), I Ba through WT subunits was reduced by 18%, whereas a 26 -28% decrease was found for the mutants (Fig. 4) . A significant difference was also found at a more negative holding potential (Ϫ80 mV, legend to Fig. 4) . The stability of I Ba in oocytes also facilitated measurements of the time course of recovery from inactivation (Fig. 5) using the double-pulse protocol described under "Experimental Procedures." Whereas G293R currents recovered with biexponential kinetics similar to WT, AY1593/1594D recovery was significantly slower mainly due to a decreased contribution of FIG. 3 . Inactivation of ␣1A, G293R, and AY1593/1594D during long test pulses. A, I Ba was elicited by 3-s pulses from a holding potential of Ϫ80 mV to a test potential 10 mV positive to V max . Traces were normalized to the peak current amplitudes. Normalized representative current traces are shown (cells: ␣1A, e0315017; G293R, e0d02047; AY1593/1594D, e1620034). Traces were fitted to a biexponential decay yielding the following time constants for the fast ( fast ) and slow ( slow ) component, the contribution of the fast component (% fast ), and residual current at the end of the pulse: ␣1A, 0.253, 1.239 s, 18%, 6.8%; G293R, 0.171, 0.621 s, 38%, 1.1%; AY1593/1594D, 0.172, 0.957 s, 33%, 2.3%. B, effect of mutations on fast and slow and the contribution of the fast component (% fast ), calculated as in A. fast : ␣1A, 0.255 Ϯ 0.01 s, n ϭ 20; G293R, 0.184 Ϯ 0.01 s, n ϭ 11; AY1593/1594D, 0.183 Ϯ 0.008 s, n ϭ 9. slow : ␣1A, 1.236 Ϯ 0.043 s; G293R, 0.726 Ϯ 0.04 s; AY1593/1594D, 0.960 Ϯ 0.03 s. % fast : ␣1A: 28.2 Ϯ 1.3%; G293R, 39.9 Ϯ 1.5%; AY1593/1594D, 33.6 Ϯ 1.5%. Data are means Ϯ S.E. Statistical significance of difference to ␣1A. *, p Ͻ 0.05; ***, p Ͻ 0.001.
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the fast recovering component (Fig. 5B) . The half-maximal voltage for steady state inactivation (V 0.5,inact ) was not changed by the mutations (Table I) . To examine possible dominant negative effects of R1279Stop on expression of wild type ␣1A, we co-injected a 20-fold excess of R1279Stop cRNA together with ␣1A/␤1a, ␣2␦. In contrast to earlier results on mutation R1820Stop (4), we were unable to detect any effect of the truncated protein on ␣1A expression (␣1A, 511 Ϯ 104 nA (n ϭ 11); ␣1AϩR1279Stop (1:20), 536 Ϯ 94 nA (n ϭ 12), means Ϯ S.E., p Ͼ 0.05).
Mutation G293R occurs within the pore-forming region of ␣1A (Fig. 1A) . As G293R was efficiently expressed in mammalian cells, we were able to determine whether this mutation alters the pore properties of the channel in single channel recordings. Unitary current to voltage relations obtained with wild type ␣1A and G293R are shown in Fig. 6A . Slope conductances calculated between Ϫ10 and ϩ20 mV were 16.3 Ϯ 0.02 (n ϭ 4) pS for WT and 16.2 Ϯ 0.02 (n ϭ 5) pS for G293R, respectively. Analysis of single channel activity in terms of open probability (P o ) and availability (P s , i.e. probability that the channel opens at least once during a depolarizing pulse), showed that P s was not altered (WT, 0.48 Ϯ 0.04; G293R, 0.45 Ϯ 0.08; at ϩ20 mV) whereas P o was, albeit not significantly, reduced in the G293R mutant (WT, 0.059 Ϯ 0.022; G293R, 0.023 Ϯ 0.01; at ϩ20 mV). Inspection of open time distributions revealed significantly (p Ͻ 0.05) reduced mean open times of G293R channels (WT, 2.9 Ϯ 0.5 ms; G293R, 1.2 Ϯ 0.02 ms, n ϭ 5, p Ͻ 0.05). Representative open time distributions at ϩ20 mV are shown in Fig. 6C . These data demonstrate that this mutation causes a substantial change in fast channel gating, which must, at least in part, account for the observed reduction of whole-cell Ba 2ϩ currents. Taken together our experiments demonstrate that G293R and AY1593/1594D can form functional Ca 2ϩ channels. Both mutants yield much lower current densities (with no detectable expression of AY1593/1594D in tsA-201 cells). In addition, they induce changes in Ca 2ϩ channel gating that predict lower Ca 2ϩ influx through these channels during single depolarizations as well as during repetitive neuronal activity.
DISCUSSION
We tested the hypothesis that ␣1A subunit mutations associated with EA-2 lead to a complete loss of mutant channel function. This hypothesis is based on the following intriguing
FIG. 4. Mutations accelerate I Ba decay during trains of pulses.
A, 1-Hz trains of 15 100-ms pulses were applied from a holding potential of Ϫ60 mV to a test potential corresponding to V max . Peak currents during each pulse were normalized to the peak I Ba during the first pulse (control) and are plotted against pulse number. Data are shown as means Ϯ S.E., n ϭ 9 -22. Peak I Ba decay after 15 pulses was as follows: ␣1A, 18.3 Ϯ 0.8 (n ϭ 22); G293R, 26.3 Ϯ 1.5 (n ϭ 11, p Ͻ 0.001); AY1593/1594D, 28.2 Ϯ 1.5 (n ϭ 9, p Ͻ 0.001). At Ϫ80 mV holding potential the following decay was observed: ␣1A, 8.8 Ϯ 0.5 (n ϭ 8); G293R, 14.6 Ϯ 0.8 (n ϭ 8, p Ͻ 0.001); AY1593/1594D, 11.7 Ϯ 0.8 (n ϭ 9, p Ͻ 0.05). B, representative current traces (Ϫ60 mV holding potential) are shown for ␣1A (cell e0316016, decay I Ba , 17.3%); G293R (cell e0d02068, 27.7%) and AY1593/1594D (cell e161022, 29.4%).
FIG. 5.
Recovery of ␣1A, G293R, and AY1593/1594D from inactivation. A, recovery from inactivation was measured using a doublepulse protocol as described under "Experimental Procedures." A representative trace of a recovery experiment is shown for G293R (cell e0d02068). B, fractional I Ba recovery from inactivation after various periods of time in seconds. Data are given as means Ϯ S.E., n ϭ 5-15. Significantly (p Ͻ 0.05) decreased recovery for AY1593/1594D after 1-3 and 5 s is indicated by asterisks. fast , slow , and the contribution of the fast component (% fast ) are shown in the inset. Statistical significance of difference to ␣1A: *, p Ͻ 0.05; **, p Ͻ 0.01.
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observations: (i) most of the genetic aberrations described in the CACNA1 gene of EA-2 patients are expected to result in truncated and thus most likely non-functional ␣1A subunits; and (ii) a previously described EA-2 missense mutation (F1491S (20) ) was devoid of channel activity. The results of our experiments do not support this hypothesis. The important findings from this study are that the EA-2-associated mutants G293R and AY1593/1594D can form functional Ca 2ϩ channels after heterologous expression in X. laevis oocytes that allowed further biophysical characterization. However, the observed changes in gating kinetics (shift of activation voltage to more positive potentials, accelerated inactivation during depolarizing pulses and during pulse trains, slower recovery from inactivation for AY1593/1594D, reduction of mean open times for G293R) must result in a significant decrease of the contribution of the mutated channel proteins to ␣1A-mediated inward currents in neurons. The positive shift of activation is in marked contrast to the previously characterized ␣1A mutations associated with FHM (6, 18, 19) . These mutations caused shifts to more negative voltages that would facilitate channel opening especially during weak depolarizations. It will therefore be important to determine whether a more positive activation range is also a characteristic for other mutations causing EA-2 or progressive ataxia.
For G293R we could provide evidence that the decrease in current was not due to a reduced single channel conductance. However, G293R channels exhibited significantly shorter mean open times. This result support our conclusion that the G293R mutation causes a modification of channel gating which is likely to account in part for reduced current density. Nonetheless, we cannot exclude at present that reduced expression of functional G293R channels also contributes to reduced current density.
Although not supporting the hypothesis that EA-2 mutations are leading to a complete loss of function, our data indicate that severe reductions in P/Q-type channel activity favor episodic and/or progressive atactic symptoms. This is also in agreement with data from spontaneous mutations in mice in which a marked reduction of P/Q-type currents in cerebellar Purkinje cells (such as in leaner (16) or ducky (17) mice) results in severe ataxia and cerebellar atrophy.
Our experiments with mutant AY1593/1594D also show that the ability of mutant ␣1A subunits to form functional Ca 2ϩ channels may differ in different heterologous expression systems. The lack of expression of AY1593/1594D in tsA-201 cells could have been misinterpreted as a general failure of this mutant to fold into a functional channel. Future investigations of disease-associated Ca 2ϩ channel ␣1A subunit mutations will be necessary to extend the ongoing genotype-phenotype correlation. For these studies we suggest that predictions about the complete loss of channel function should be based on experiments in more than one heterologous expression system. As a consequence, it will be important to test if functional expression of the EA-2 mutant F1491S, which gives rise to a fulllength ␣1A protein but yields no detectable currents after expression in mammalian cells (20) , can be achieved in X. laevis oocytes.
The fact that no functional channels were formed in either expression system by R1279Stop is in accordance with the hypothesis that structural aberrations resulting in loss of membrane spanning regions result in a complete loss of channel function. The question remains if these shorter proteins can exert dominant negative effects. Interestingly, all predicted truncations reported so far (5, 29 -31) occur after transmembrane segment IIS1 thus allowing the truncated mutant to contain an intact ␤ subunit interaction domain in the I-II linker (32) . Although it is at present unclear if truncated ␣1A proteins reach the plasma membrane, they could compete with intact ␣1A subunits for ␤ subunit binding and its subsequent complex formation and membrane targeting. Here we found no evidence for a dominant negative effect. This is in contrast to mutant R1820Stop which contains all transmembrane repeats but lacks the C-terminal tail (4). This construct, when coexpressed with ␣1A/␤1/␣2␦, reduces ␣1A-mediated currents. This effect could not be explained by ␤ subunit depletion, and the molecular mechanism remains unknown.
